News
TMDX
77.87
-1.43%
-1.13
Stryker, Abbott among Overweight ideas as Barclays turns bullish on MedTech
Seeking Alpha · 3d ago
Flutter upgraded, AppFolio downgraded: Wall Street’s top analyst calls
TipRanks · 3d ago
TransMedics Group Initiated at Overweight by Barclays
Dow Jones · 3d ago
TransMedics Group Price Target Announced at $120.00/Share by Barclays
Dow Jones · 3d ago
Barclays Initiates Coverage On TransMedics Group with Overweight Rating, Announces Price Target of $120
Benzinga · 3d ago
Most shorted stocks on Wall Street
Seeking Alpha · 5d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 5d ago
Weekly Report: what happened at TMDX last week (0928-1002)?
Weekly Report · 5d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: TransMedics Group (TMDX), Regeneron (REGN) and Tarsus Pharmaceuticals (TARS)
TipRanks · 10/02 12:30
Analyst Reiterates Buy on TransMedics, Citing Strong Near-Term Revenue Upside and Multiple Long-Term Growth Catalysts
TipRanks · 10/02 09:15
Weekly Report: what happened at TMDX last week (0921-0925)?
Weekly Report · 09/28 09:47
TransMedics Offers An Attractive Entry Point, With Upside Potential Outweighing Risks
Seeking Alpha · 09/26 11:56
Analysts Offer Insights on Healthcare Companies: DBV Technologies SA – American (DBVT) and TransMedics Group (TMDX)
TipRanks · 09/22 09:50
Weekly Report: what happened at TMDX last week (0914-0918)?
Weekly Report · 09/21 09:47
TransMedics: Waiting On 2027 Catalysts (Rating Upgrade)
Seeking Alpha · 09/18 08:16
TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX
Barchart · 09/14 13:39
Weekly Report: what happened at TMDX last week (0907-0911)?
Weekly Report · 09/14 09:50
Analysts Have Conflicting Sentiments on These Healthcare Companies: Disc Medicine (IRON), TransMedics Group (TMDX) and Lyell Immunopharma (LYEL)
TipRanks · 09/11 12:02
Analysts’ Opinions Are Mixed on These Healthcare Stocks: TransMedics Group (TMDX) and Hims & Hers Health (HIMS)
TipRanks · 09/11 11:50
Canaccord Genuity Keeps Their Buy Rating on TransMedics Group (TMDX)
TipRanks · 09/11 11:36
More
Webull provides a variety of real-time TMDX stock news. You can receive the latest news about Transmedics Group through multiple platforms. This information may help you make smarter investment decisions.
About TMDX
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.